Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testagen TDS-Testosterone transfer pharmacokinetic study
2013-001767-23Phase 2Unknown
- Sponsor
- Seahorse Scientific Services
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Testagen in Hypoandrogenism (TD), sponsored by Seahorse Scientific Services. Primary endpoint: Potential transfer of testosterone to female companions. Status: unknown.
02
Drugs
Testagen
03
Conditions
Hypoandrogenism (TD)
Beyond the preview
Go deeper on 2013-001767-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001767-23.